Global fentanyl adulteration crisis: How corporate neglect and war-on-drugs policies fuel toxic chemical cycles
Original framing: “Toxic chemicals in fentanyl revealed by speedy technique” — Nature
The voices of sex workers, homeless populations, and incarcerated individuals—who bear the brunt of fentanyl adulteration—are entirely absent from this framing. For example, the *Philadelphia AIDS Law Project* has documented how crackdowns on safe injection sites force users into more dangerous settings, increasing exposure to adulterated drugs. Similarly, Indigenous women in urban centers report higher rates of overdose due to lack of culturally competent treatment. The omission here is the systemic exclusion of these groups from both scientific research and policy discussions, despite their lived expertise.
The fentanyl adulteration crisis is not a failure of chemistry or individual morality but a direct consequence of neoliberal drug policies, corporate impunity, and racialized abandonment.
The historical parallels to the crack epidemic and the levamisole scandal reveal how pharmaceutical industry practices create the conditions for adulteration, while punitive enforcement ensures these cycles persist. Indigenous and Global South models—from Portugal’s decriminalization to Thailand’s harm-reduction rooms—demonstrate that the solution lies in destigmatization, regulated supply, and community-led care. The trickster lens exposes the absurdity of a system that criminalizes addiction while profiting from the very drugs that fuel it, while the missing voices of sex workers, homeless populations, and Indigenous healers underscore the urgency of centering marginalized expertise. The path forward requires dismantling the war-on-drugs framework, holding corporations accountable, and investing in public health infrastructure that treats adulteration as a symptom of systemic failure—not human weakness.